Advanced search
1 file | 259.64 KB Add to list

The ProLimus trial: a prospective, non-randomised, multicenter trial to evaluate the safety and clinical performance of the pimecrolimus eluting stent system (ProGenic)

(2009) EUROINTERVENTION. 5(2). p.233-238
Author
Organization

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 259.64 KB

Citation

Please use this url to cite or link to this publication:

MLA
Verheye, Stefan, Giovanna Sarno, Ralf Müller, et al. “The ProLimus Trial: a Prospective, Non-randomised, Multicenter Trial to Evaluate the Safety and Clinical Performance of the Pimecrolimus Eluting Stent System (ProGenic).” EUROINTERVENTION 5.2 (2009): 233–238. Print.
APA
Verheye, S., Sarno, G., Müller, R., Birkemeyer, R., Vrints, C., Jung, W., Agostoni, P., et al. (2009). The ProLimus trial: a prospective, non-randomised, multicenter trial to evaluate the safety and clinical performance of the pimecrolimus eluting stent system (ProGenic). EUROINTERVENTION, 5(2), 233–238.
Chicago author-date
Verheye, Stefan, Giovanna Sarno, Ralf Müller, Ralf Birkemeyer, Christiaan Vrints, Werner Jung, Pierfrancesco Agostoni, et al. 2009. “The ProLimus Trial: a Prospective, Non-randomised, Multicenter Trial to Evaluate the Safety and Clinical Performance of the Pimecrolimus Eluting Stent System (ProGenic).” Eurointervention 5 (2): 233–238.
Chicago author-date (all authors)
Verheye, Stefan, Giovanna Sarno, Ralf Müller, Ralf Birkemeyer, Christiaan Vrints, Werner Jung, Pierfrancesco Agostoni, Glenn Vanlangenhove, Steven Haine, Tine Willems, Michael Haude, Eberhart Grube, and William Wijns. 2009. “The ProLimus Trial: a Prospective, Non-randomised, Multicenter Trial to Evaluate the Safety and Clinical Performance of the Pimecrolimus Eluting Stent System (ProGenic).” Eurointervention 5 (2): 233–238.
Vancouver
1.
Verheye S, Sarno G, Müller R, Birkemeyer R, Vrints C, Jung W, et al. The ProLimus trial: a prospective, non-randomised, multicenter trial to evaluate the safety and clinical performance of the pimecrolimus eluting stent system (ProGenic). EUROINTERVENTION. 2009;5(2):233–8.
IEEE
[1]
S. Verheye et al., “The ProLimus trial: a prospective, non-randomised, multicenter trial to evaluate the safety and clinical performance of the pimecrolimus eluting stent system (ProGenic),” EUROINTERVENTION, vol. 5, no. 2, pp. 233–238, 2009.
@article{1058581,
  author       = {Verheye, Stefan and Sarno, Giovanna and Müller, Ralf and Birkemeyer, Ralf and Vrints, Christiaan and Jung, Werner and Agostoni, Pierfrancesco and Vanlangenhove, Glenn and Haine, Steven and Willems, Tine and Haude, Michael and Grube, Eberhart and Wijns, William},
  issn         = {1774-024X},
  journal      = {EUROINTERVENTION},
  language     = {eng},
  number       = {2},
  pages        = {233--238},
  title        = {The ProLimus trial: a prospective, non-randomised, multicenter trial to evaluate the safety and clinical performance of the pimecrolimus eluting stent system (ProGenic)},
  volume       = {5},
  year         = {2009},
}